17,261 trials
XMEN
Primary: Participants With a ≥0.5 Log Reduction in the Number of EBV-infected B Cells After Magnesium Supplementation as Compared to Placebo - Phase 1 — 0; 0 Participants
Dry Eye
Primary: Coprimary Endpoint: Change From Baseline in Inferior Corneal Staining Score to Day 57 (Pre-CAE) — 1.94; 1.96; 1.95; 0.10 score on a scale — p=0.3378
Avian Influenza · H1N1 Influenza · Influenza
Primary: Percentage of Participants Achieving Seroconversion Based on HAI Titer (A/H7N9 Vaccine, With and Without Adjuvant) — 80.0; 0 percentage of participants
Retinal Vein Occlusion
Primary: Mean Change in Best-corrected Visual Acuity (BCVA) in the Study Eye at 12 Months Compared to Baseline. — 5.3; 13.0 ETDRS letters
Macrophage Activation Syndrome · Lymphohistiocytosis, Hemophagocytic · Arthritis, Juvenile
Primary: Incidence, Severity, Causality, and Outcomes of AEs (Serious and Nonserious) — 13; 6; 2; 10 Participants
Pain, Acute
Primary: Sum of the Time-weighted Differences From Baseline in Pain Intensity With Movement(SPIDMOVE) Over 24 Hours Post Time Zero — -33.09; -29.09 score on a scale*hours…
Metastatic Squamous Cell Carcinoma of the Hypopharynx · Metastatic Squamous Cell Carcinoma of the Larynx · Metastatic Squamous Cell Carcinoma of the Oral Cavity
Primary: Progression Free Survival (PFS) — 6.08; 4.4 months
Cystic Fibrosis
Primary: Absolute Change in Percent Predicted Forced Expiratory Volume in 1 Second (ppFEV1) — -0.8; 3.1; 2.7 percentage points
Advanced Cancer
Primary: The Number of Participants Experiencing Dose-Limiting Toxicities (DLTs) — 0; 0; 0; 0 Participants
Cocaine Dependence
Primary: Those Achieving Three Consecutive Weeks of Cocaine Abstinence at the End of the Trial. — 7; 5 Participants
Adult Acute Myeloid Leukemia in Remission · Recurrent Adult Acute Myeloid Leukemia
Primary: Relapse-free Survival in Days — 142 days
Juvenile Pilocytic Astrocytomas · Optic Pathway Gliomas
Primary: Number of Children Responding to Treatment — 0; 0; 5 Participants
Healthy
Primary: Cumulative Stress Index — 647; 676 mmHg x minutes
Irritable Bowel Syndrome · Abdominal Pain · Colonic Diseases
Primary: T-max — 360; 180 minutes
Coronavirus Disease 2019 (COVID-19)
Primary: The Percent of Participants With Tracheal Intubation or Death Prior to Tracheal Intubation — 26.2; 22.2 percentage of participants